Gabriel
Reina González
Investigador Consultor
![Foto de Gabriel](/img/uploaded/4D312AE37C7DA143EA30C1D5086ED966.jpg)
![Foto de Instituto de Investigación Sanitaria de Navarra](/img/noimage_org.png)
Instituto de Investigación Sanitaria de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (23)
2024
-
High pre-Delta and early-Omicron SARS-CoV-2 seroprevalence detected in dried blood samples from Kinshasa (D.R. Congo)
Journal of Medical Virology, Vol. 96, Núm. 3
-
Nipah Virus: A Multidimensional Update
Viruses, Vol. 16, Núm. 2
-
Prevalence of Paid Sex and Associated Factors Among Women and Men Attending HIV Voluntary Counseling and Testing in Kinshasa, Democratic Republic of the Congo: A Prospective Cohort
Archives of Sexual Behavior
2023
-
COVID-19 risk, course and outcome in people with mental disorders: a systematic review and meta-analyses
Epidemiology and psychiatric sciences, Vol. 32, pp. e61
-
Corrigendum: Increased levels of interleukin-36 in obesity and type 2 diabetes fuels adipose tissue inflammation by inducing its own expression and release by adipocytes and macrophages(Front. Immunol., (2022), 13, (832185), 10.3389/fimmu.2022.832185)
Frontiers in Immunology
-
Effect of the Hematocrit and Storage Temperature of Dried Blood Samples in the Serological Study of Mumps, Measles and Rubella
Diagnostics, Vol. 13, Núm. 3
-
Impact of storage time in dried blood samples (DBS) and dried plasma samples (DPS) for point-of-care hepatitis C virus (HCV) RNA quantification and HCV core antigen detection
Microbiology Spectrum, Vol. 11, Núm. 5
-
Photodynamic nasal SARS-CoV-2 decolonization shortens infectivity and influences specific T-Cell responses
Frontiers in Cellular and Infection Microbiology, Vol. 13
-
Rocahepevirus ratti as an Emerging Cause of Acute Hepatitis Worldwide
Microorganisms, Vol. 11, Núm. 12
-
SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: Systematic review with frequentist and Bayesian meta-analyses
British Journal of Psychiatry, Vol. 223, Núm. 2, pp. 348-361
2022
-
Characterization of Human Papillomavirus 16 from Kinshasa (Democratic Republic of the Congo)—Implications for Pathogenicity and Vaccine Effectiveness
Microorganisms, Vol. 10, Núm. 12
-
Diagnosis of COVID-19. What have we learned after two years of the pandemic?
Advances in Laboratory Medicine, Vol. 3, Núm. 2, pp. 97-99
-
Humoral and cellular immune response over 9 months of mRNA-1273, BNT162b2 and ChAdOx1 vaccination in a University Hospital in Spain
Scientific Reports, Vol. 12, Núm. 1
-
Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Response in the Lungs of Patients With Fatal COVID-19
Chest, Vol. 162, Núm. 5, pp. 1006-1016
2021
-
HIV-1 diagnosis using dried blood spots from patients in Kinshasa, DRC: a tool to detect misdiagnosis and achieve World Health Organization 2030 targets
International Journal of Infectious Diseases, Vol. 111, pp. 253-260
-
Hcv diagnosis and sequencing using dried blood spots from patients in kinshasa (Drc): A tool to achieve who 2030 targets
Diagnostics, Vol. 11, Núm. 3
-
Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies
Translational Research, Vol. 232, pp. 60-74
-
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses
Emerging Microbes and Infections, Vol. 10, Núm. 1, pp. 1931-1946
-
Predictors of retention in the prospective HIV prevention OKAPI cohort in Kinshasa
Scientific reports, Vol. 11, Núm. 1, pp. 5431
-
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial
EClinicalMedicine, Vol. 32